Mechanisms and cross-talk of regulated cell death and their epigenetic modifications in tumor progression

Ruimin He1,2,3, Yifan Liu1,2,3, Weijie Fu1,2,3

  • 1Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, 410078, China.

Molecular Cancer
|November 29, 2024
PubMed

Insights

This review explores cell death mechanisms and epigenetic regulation in cancer. Understanding these processes is crucial for developing novel tumor therapies that target abnormal cell elimination.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Epigenetics

Background:

  • Cell death is essential for multicellular organism homeostasis and preventing tumorigenesis.
  • Inhibition of cell death pathways contributes to tumor development and chemoresistance.
  • Epigenetic modifications play a significant role in regulating cell death, but their interplay in cancer remains incompletely understood.

Purpose of the Study:

  • To review the diverse mechanisms of cell death pathways.
  • To summarize the epigenetic regulations governing these cell death pathways.
  • To explore the interactions between cell death and epigenetics for potential cancer therapy.

Main Methods:

  • Literature review of cell death mechanisms and epigenetic controls.
  • Analysis of the 2018 Cell Death Nomenclature Committee (NCCD) classification.
  • Exploration of mechanistic relationships and interactions.

Main Results:

  • Cell death is classified into 12 types, including apoptosis, necroptosis, ferroptosis, and others.
  • Epigenetic mechanisms intricately regulate various cell death pathways.
  • Interactions between cell death pathways and epigenetic controls offer therapeutic opportunities.

Conclusions:

  • Understanding cell death and epigenetic interplay is vital for cancer research.
  • Targeting cell death pathways through epigenetic modulation shows promise for cancer treatment.
  • Further investigation into these mechanisms can lead to innovative anti-cancer drug development.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K